Vliv autoplazmy obohacené o krevní destičky na tloušťku endometria a citlivost receptorů pro estrogen a progesteron

Download PDF English version

Authors: YYuliya V. Zabrodina ^1,2; Konstantin Yu. Boyarsky ^3,4; Gainyl U. Akhmedyanova ^1,2; Zaituna G. Khamidullina ^1,2
Authors‘ workplace: Astana Medical University, Astana, Kazakhstan ¹; Department of Obstetrics and Gynecology, No. 1 Astana medical university, Astana, Kazakhstan ²; Department of Obstetrics and Gynecology, S. N. Davydov Pediatric Faculty SZGMU I. I. Mechnikov, Saint-Petersburg, Russia ³; Center for Reproduction, Genesis, Saint-Petersburg, Russia ⁴
Published in: Ceska Gynekol 2024; 89(3): 203-209
Category: Original Article
doi: https://doi.org/10.48095/cccg2024203

Overview

Cíl: Vliv autoplazmy obohacené o krevní destičky na tloušťku endometria a citlivost receptorů na estrogen a progesteron. Materiál a metody: Do této prospektivní studie bylo zařazeno 200 pacientek. Účastnice studie byly rozděleny do dvou skupin. První, kontrolní skupina dostávala hormonální substituční terapii (HRT – hormone replacement therapy). Druhá, studijní skupina dostávala intrauterinní infuzi autoplazmy obohacené o krevní destičky (PRP – platelet-rich autoplasma). Devatenáctý den menstruačního cyklu bylo provedeno ultrazvukové vyšetření s cílem zhodnotit tloušťku endometria a dále imunohistochemická analýza k stanovení citlivosti receptorů pro estrogen a progesteron. Výsledky: Během studie jsme zjistili, že po podání autoplazmy obohacené o krevní destičky se zvýšila tloušťka endometria o 0,85 mm; průměrná tloušťka endometria ve skupině na terapii PRP byla 8,25 mm (8,25–8,61 mm) a ve skupině pacientek, které dostávaly pouze HRT, byla 7,40 mm (7,34–7,65 mm). Citlivost receptorů pro estrogen se v experimentální skupině zvýšila o 3,5, přičemž v této skupině dosáhla hodnoty 75,00 (71,43–74,22) a v kontrolní skupině 71,50 (67,05–70,85). Citlivost receptorů pro progesteron se zvýšila o 9,0, hodnota v této skupině byla 95,0 (91,4–93,8) a v kontrolní skupině 86,0 (83,47–86,27). Závěr: Díky působení destičkových faktorů má terapie PRP pozitivní vliv na endometrium, kdy zvyšuje jeho tloušťku a zlepšuje receptivitu. Je tedy možné vyvodit závěr, že tato metoda zřejmě nalezne velké praktické uplatnění při zlepšování výsledků programů asistované reprodukce.

Klíčová slova:

neplodnost – autoplazma obohacená o krevní destičky – nízké endometrium

Sources

1. Bu Z, Wang K, Dai W et al. Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles. Gynecol Endocrinol 2016; 32 (7): 524–528. doi: 10.3109/09513590.2015.1136616.

2. Gao G, Cui X, Li S et al. Endometrial thickness and IVF cycle outcomes: a meta-analysis. Reprod Biomed Online 2020; 40 (1): 124–133. doi: 10.1016/j.rbmo.2019.09.005.

3. Mahajan N, Sharma S. The endometrium in assisted reproductive technology: How thin is thin? J Hum Reprod Sci 2016; 9 (1): 3–8. doi: 10.4103/0974-1208.178632.

4. Kasius A, Smit JG, Torrance HL et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 2014; 20 (4): 530–541. doi: 10.1093/humupd/dmu011.

5. Liu KE, Hartman M, Hartman A et al. The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes: an analysis of over 40 000 embryo transfers. Hum Reprod 2018; 33 (10): 1883–1888. doi: 10.1093/ humrep/dey281.

6. Wu Y, Gao X, Lu X et al. Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration. Reprod Biol Endocrinol 2014; 12: 96. doi: 10.1186/1477-7827-12-96.

7. Fang R, Cai L, Xiong F et al. The effect of endometrial thickness on the day of hCG administration on pregnancy outcome in the first fresh IVF/ICSI cycle. Gynecol Endocrinol 2016; 32 (6): 473–476. doi: 10.3109/09513590.2015.1132304.

8. Barash A, Dekel N, Fieldust S et al. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril 2003; 79 (6): 1317–1322. doi: 10.1016/ s0015-0282 (03) 00345-5.

9. Nastri CO, Ferriani RA, Raine-Fenning NJ et al. Endometrial injury performed in the non-transfer cycle and assisted reproduction outcomes: a randomized controlled trial. Ultrasound Obstet Gynecol 2013; 42 (4): 375–382. doi: 10.1002/uog.12539.

10. Chen MJ, Yang JH, Peng FH et al. Extended estrogen administration for women with thin endometrium in frozen-thawed in vitro fertilization programs. J Assist Reprod Genet 2006; 23 (7): 337–342. doi: 10.1007/s10815-006-9053-1.

11. Hashemi Z, Sharifi N, Khani B et al. The effects of vitamin E supplementation on endometrial thickness, and gene expression of vascular endothelial growth factor and inflammatory cytokines among women with implantation failure. J Matern Fetal Neonatal Med 2019; 32 (1): 95–102. doi: 10.1080/14767058.2017.1372413.

12. Amable PR, Carias RB, Teixeira MV et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013; 4 (3): 67. doi: 10.1186/scrt218.

13. Lee JW, Kwon OH, Kim TK et al. Platelet‐rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013; 40 (5): 530–535. doi: 10.5999/aps.2013.40.5.530.

14. Eftekhar M, Neghab N, Naghshineh E et al. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol 2018; 57 (6): 810–813. doi: 10.1016/j.tjog.2018.10.007.

15. Bertrand-Duchesne MP, Grenier D, Gagnon G. Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro. J Periodontal Res 2010; 45 (1): 87–93. doi: 10.1111/j.1600-0765.2009.01205.x.

16. Kusumi M, Ihana T, Kurosawa T et al. Intrauterine administration of platelet-rich plasma improves embryo implantation by increasing the endometrial thickness in women with repeated implantation failure: a single-arm self--controlled trial. Reprod Med Biol 2020; 19 (4): 350–356. doi: 10.1002/rmb2.12334.

17. Zabrodina YV, Akhmediyanova GU, Khamidullina ZG. Use of platelet-rich autoplasma in the assisted reproductive technology programs. Akusherstvo i Ginekologiya 2023; 7: 5–11. doi: 10.18565/aig.2023.63.

18. Chang Y, Li J, Chen Y et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med 2015; 8 (1): 1286–1290.

19. Zadehmodarres S, Salehpour S, Saharkhiz N et al. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod 2017; 21 (1): 54–56. doi: 10.5935/1518-0557.20170013.

20. Molina A, Sánchez J, Sánchez W et al. Platelet-rich plasma as an adjuvant in the endometrial preparation of patients with refractory endometrium. JBRA Assist Reprod 2018; 22 (1): 42–48. doi: 10.5935/1518-0557.20180 009.

21. Tandulwadkar SR, Naralkar MV, Surana AD et al. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: a pilot study. J Hum Reprod Sci 2017; 10 (3): 208–212. doi: 10.4103/jhrs.JHRS_28_17.

22. Agarwal M, Mettler L, Jain S et al. Management of a thin endometrium by hysteroscopic instillation of platelet‐rich plasma into the endomyometrial junction: a pilot study. J Clin Med 2020; 9 (9): 2795. doi: 10.3390 /jcm9092795.

23. Frantz N, Ferreira M, Kulmann MI et al. Platelet-rich plasma as an effective alternative approach for improving endometrial receptivity – a clinical retrospective study. JBRA Assist Reprod 2020; 24 (4): 442–446. doi: 10.5935/ 1518-0557.20200026.

24. Zamaniyan M, Peyvandi S, Gorji HH et al. Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial. Gynecol Endocrinol 2021; 37 (2): 141–145. doi: 10.1080/09513590.2020.1756247.

25. Maleki-Hajiagha A, Razavi M, Rouholamin S et al. Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction: a systematic review and meta-analysis. J Reprod Immunol 2020; 137: 103078. doi: 10.1016/j.jri.2019.103078.

26. Abduljabbar HS, Howida H, Abduljabbar HH et al. The effect of autologous platelet-rich plasma treatment on in vitro fertilization/intracytoplasmic sperm injection and its impact on the endometrium and clinical pregnancy rate. Cureus 2022; 14 (8): e27913. doi: 10.7759/cureus.27913.

27. Ojosnegros S, Seriola A, Godeau AL et al. Embryo implantation in the laboratory: an update on current techniques. Hum Reprod Update 2021; 27 (3): 501–530. doi: 10.1093/humupd/ dmaa054.

28. Chen YH, Zhang XL, Fan JM et al. The possible window of implantation for embryos in the first frozen embryo transplantation cycle: a retrospective analysis. Transpl Immunol 2022; 72: 101582. doi: 10.1016/j.trim.2022.10582.

29. Enciso M, Aizpurua J, Rodríguez-Estrada B et al. The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep 2021; 11 (1): 13420. doi: 10.1038/s41598-021-92955-w.

30. Casper R, Yanushpolsky E. Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril 2016; 105 (4): 867–872. doi: 10.1016/j.fertnstert.2016.01. 006.

ORCID authors

Y. V. Zabrodina 0000-0001-8972-0300

K. Yu. Boyarsky 0000-0002-2000-1567

G. U. Akhmedyanova 0000-0002-5410-7781

Z. G. Khamidullina 0000-0002-0902-5269

Submitted/Doručené: 4. 12. 2023

Accepted/Přijaté: 23. 1. 2024

Yuliya V. Zabrodina, MD

Astana Medical University

Beibitshilik St 49/A

010000 Astana

Kazakhstan